Global intravenous (IV) iron and oral iron market is expected to cross US$ 3 billion by 2021, growing at a CAGR of 5%.
Iron drugs are the supplements containing iron prescribed by a doctor to treat anemia or other iron deficiencies. Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body and intravenous (IV) iron therapy comes into the picture.
Global Intravenous (IV) Iron and Oral Iron market research report covers the present scenario and the growth prospects of the iron drugs market for the period 2016-2021. The report provides in-depth market analysis of market size and growth of Global Intravenous (IV) Iron and Oral Iron market.
For more information about this report: http://www.reportsweb.com/global-intravenous-iv-iron-and-oral-iron-market-strategic-assessment-and-forecast-till-2021
Scope of the Report:
This market research report categories the Global Intravenous (IV) Iron and Oral Iron market based on mode of delivery, therapeutic area and geography. This market research includes a detailed market segmentation of the worldwide Intravenous (IV) iron and oral market by
By Mode of Delivery
-Intravenous (IV) Iron
-Iron Dextran Complex
By Therapeutic Area
-Gynecology and Obstetrics
-Chronic Heart Failures
-Patient Blood Management
Global Intravenous (IV) Iron and Oral Iron Market – Market Size and Dynamics
Analysts at Publisher expects the global intravenous (IV) iron and oral iron market to cross US$ 3 billion by 2021, growing at an impressive CAGR close to 5%. Iron drugs are widely used in various therapeutic areas like nephrology, gynaecology, oncology, gastroenterology, surgeries, and chronic heart failures. This catalyses the growth of global intravenous (IV) iron and oral iron market. Furthermore, factors such as correction of IDA in pregnancy, growing diabetic population worldwide, growing incidence of Chronic Kidney Disease (CKD) that increases the need of dialysis, prevalence of iron deficiency are the major factors attributing to the growth of the market.
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001576037/sample
The global intravenous (IV) iron and oral iron market is majorly categorised into two categories as per there mode of delivery such as oral and intravenous (IV) . The oral delivery of iron in form of tablets, capsules, syrups is the most economic medical treatment for iron deficiency anaemia. Ferrous sulfate is the most common and cheapest form of oral therapy for treating patients with iron deficiency anemia. Though oral iron drugs market size is expected to increase to a notable figure over next five years, it can lose significant amount of its market share to intravenous (IV) iron therapies in near future.
Intravenously iron is delivered to patients who are either unable to absorb oral iron or who has increasing anemia despite adequate doses of oral iron. Growing incidence of Chronic Kidney Disease (CKD) , iron deficiency diseases related to gynecology, nephrology, gastroenterology, and oncology is driving growth of the intravenous iron therapy. The high growth rate of IV iron market can be attributed to the paradigm shift of healthcare providers/patients to IV iron therapies from oral iron therapies.
The research report provides a detailed analysis and growth forecast of each therapeutic area. Nephrology is the largest application area of the intravenous (IV) iron and oral iron drugs followed by Gynecology and Gastroenterology.
Global Intravenous (IV) Iron and Oral Iron – Trends, Drivers, and Challenges
The market research report on intravenous (IV) iron and oral iron market provides a comprehensive study about the factors affecting the market growth and upcoming challenges. The research report describes the growth driving factors of the global intravenous (IV) iron and oral iron market for the next five years. Increasing number of dialysis patients and growing diabetic population worldwide are among the major drivers described in the intravenous (IV) iron and oral iron market research report.
Paradigm shift from oral iron drugs to intravenous (IV) iron drugs is a major trend in the market. There are gastrointestinal side effects associated with oral iron drugs like nausea, constipation, anorexia, heartburn, vomiting, and diarrhea and are intolerant even by healthy patients. Thus the side effects of oral iron drugs has attracted the patients towards intravenous (IV) iron. Also with the increasing awareness of IDA during pregnancy and shift towards healthier lifestyle; correction of IDA in pregnant women is the current trend driving the market for oral and IV iron.
Today, the trend is driving towards focus on healthy diet, healthy lifestyle, adoption of healthy solutions to build health. Thus, intake of healthy diet and nutraceuticals is a blooming alternative for daily medication for nutrient deficiency like iron deficiency. Hence, focus on healthy diet and nutraceuticals is one of the major challenges included in the report
Global Intravenous (IV) Iron and Oral Iron – Key Market Growth Opportunities
The report outlines the major growth opportunities in global intravenous (IV) iron and oral iron market. It includes a detailed description of the opportunities for the year 2016-2021. Huge patient population undergoing dialysis and patient blood management are among the notable growth opportunities in the global intravenous (IV) iron and oral iron market. For patients suffering from severe anaemia or haemorrhage, blood transfusions are proved to be life-saving. As the cost of blood transfusions is high, there are adverse outcomes of blood transfusion, and due to the questionable efficacy of transfusions the demand for patient blood management can be expected to rise; thus, opening arenas for iron therapies.
The report also provides the Porter’s five forces analysis along with a description of each of the forces and its impact on the market.
Global Intravenous (IV) Iron and Oral Iron – Geographical Analysis
The report includes the market analysis of global intravenous (IV) iron and oral iron market in different regions such as the Americas, APAC, and EMEA. The report outlines the major market share holder in the global intravenous (IV) iron and oral iron market and the market size analysis of all the regions. The intravenous (IV) iron and oral iron market report also provides the market size and forecast of the key countries. The America region is expected to be the largest market for intravenous (IV) iron and oral iron drugs followed by EMEA. US, Canada, and Brazil are the key countries in this region contributing a major chunk of revenue.
Large population of people suffering from CKD, diabetes and undergoing dialysis is going to spur the market for intravenous (IV) iron and oral iron in European nations. Likewise, in APAC region large population of people suffering from diabetes in major countries such as China, Japan, and India is going to propel the demand for intravenous (IV) iron and oral iron drugs. In addition, the increasing number of people undergoing renal replacement therapies in Australia and New Zealand, is expected to boost the market for intravenous (IV) iron and oral iron drugs.
Global Intravenous (IV) Iron and Oral Iron – Market Share and Key Vendors
This market research report profiles the major companies in the global intravenous (IV) iron and oral iron drugs market and also provides the competitive landscape and in-depth profile of key players. Within the report covers the entire market outlook regarding the value chain operating within the market. The major players in the market include
The other leading vendors in the global intravenous (IV) iron and oral iron market include Sanofi, Arbro Pharmaceuticals, Solace Biotech, ALDE MEDI IMPEX, American Biocare.
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001576037/buying